An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Four-year results of a phase III trial showed that budesonide oral suspension (Eohilia) for eosinophilic esophagitis was well ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Blockages in coronary arteries cause sudden heart attacks, leading to heart muscle damage. In contrast, heart failure is a ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

In South Dallas, a local nonprofit is working to address disparities that affect life expectancy and heart disease outcomes ...

Background Iron deficiency (ID) is common in patients with atrial fibrillation/flutter (AF), but its prognostic implications and optimal diagnostic criteria, particularly in those with and without ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Heart failure doesn’t always come with loud warnings. It is therefore important to listen to your body, recognise the silent ...

Dr. Aseem Malhotra, a cardiologist and public health campaigner based in London, says Americans' foods are fueling chronic ...